The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved

An Erratum to this article was published on 01 August 1996

References

  1. 1.

    Lam KSL, Cheng IKP, Janus ED, Pang RWC (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604–609

    Google Scholar 

  2. 2.

    Andersen B (1990) Methodological errors in medical research. Blackwell, Oxford London Edinburgh Boston Melbourne Paris Berlin Vienna

    Google Scholar 

  3. 3.

    Crowder MJ, Hand DJ (1990) Analysis of repeated measures. Chapman and Hall, London New York Tokyo Melbourne Madras

    Google Scholar 

  4. 4.

    Senn S (1994) Testing for baseline balance in clinical trials. Stat Med 13: 1715–1726

    Google Scholar 

  5. 5.

    Matthews JNS, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300: 230–235

    Google Scholar 

References

  1. 1a.

    Lam KSL, Cheng IKP, Janus ED, Pang RWC (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604–609

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Dr. R. Bender or Dr. K. S. L. Lam or Dr. I. J. Lauder.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF00403925.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bender, R., Lam, K.S.L. & Lauder, I.J. The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved. Diabetologia 39, 368–370 (1996). https://doi.org/10.1007/BF00418357

Download citation

Keywords

  • Public Health
  • Internal Medicine
  • Human Physiology
  • Metabolic Disease
  • Diabetic Nephropathy